Results 31 to 40 of about 1,463,832 (396)

Short‐term efficacy and long‐term survival of nasopharyngeal carcinoma patients with radiographically visible residual disease following observation or additional intervention: A real‐world study in China

Laryngoscope Investigative Otolaryngology, 2022
Background To explore the short‐ and long‐term outcomes in patients with nasopharyngeal carcinoma (NPC) with magnetic resonance imaging (MRI)‐detected residual disease at 3 months post‐treatment who received intervention either promptly (0 month) or ...
Ying‐Ying Huang, Xun Cao, Zhuo‐Chen Cai, Jia‐Yu Zhou, Xiang Guo, Xing Lv   +5 more
doaj   +1 more source

Increased Angiogenin Expression Correlates With Radiation Resistance and Predicts Poor Survival for Patients With Nasopharyngeal Carcinoma

Frontiers in Pharmacology, 2021
Background: Despite the development of such multiple therapeutic approaches, approximately 20% patients experience recurrence. Identification of molecular markers for stratifying the different risks of tumour recurrence and progression is considered ...
Shan-Shan Guo, Shan-Shan Guo, Yu-Jing Liang, Yu-Jing Liang, Li-Ting Liu, Li-Ting Liu, Qiu-Yan Chen, Qiu-Yan Chen, Yue-Feng Wen, Yue-Feng Wen, Yue-Feng Wen, Sai-Lan Liu, Sai-Lan Liu, Xue-Song Sun, Xue-Song Sun, Qing-Nan Tang, Qing-Nan Tang, Xiao-Yun Li, Xiao-Yun Li, Hai-Qiang Mai, Hai-Qiang Mai, Lin-Quan Tang, Lin-Quan Tang   +22 more
doaj   +1 more source

A regulatory mutant on TRIM26 conferring the risk of nasopharyngeal carcinoma by inducing low immune response. [PDF]

, 2018
The major histocompatibility complex (MHC) is most closely associated with nasopharyngeal carcinoma (NPC), but the complexity of its genome structure has proven challenging for the discovery of causal MHC loci or genes.
Cheng, Zhi, Dong, Lei, Han, Ming-Yu, Huang, Zhong-Xi, Jiang, Tao, Li, Jin-Bang, Li, Xin, Li, Xin, Liu, Teng-Fei, Liu, Xiao, Long, Xiao-Bing, Lyu, Xiao-Ming, Qiu, Mo-Chang, Sun, Tao, Wang, Jia-Hong, Wang, Jian-Guo, Wang, Qian, Wang, Shuang, Wei, Gan-Guan, Yang, Xue-Xi, Yao, Kaitai, Zhang, Bo, Zhang, Long-Cheng, Zhao, Manli, Zheng, Hou-Feng, Zheng, Lu, Zhu, Xiao-Wei, Zuo, Xian-Bo   +27 more
core   +2 more sources

Targeting the IRAK1–S100A9 Axis Overcomes Resistance to Paclitaxel in Nasopharyngeal Carcinoma

Cancer Research, 2021
Deregulation of the IRAK1–S100A9 axis correlates with poor prognosis, contributes to chemoresistance in nasopharyngeal carcinoma, and can be targeted by pacritinib to overcome chemoresistance in nasopharyngeal carcinoma.
Li-zhen Liu, Sai-Lan Liu, Peng Deng, Yu-fan Liang, Rong Xiao, L. Tang, Jinghong Chen, Qiu-Yan Chen, P. Guan, Shumei Yan, Xiangliang Huang, J. Hong, Jianfeng Chen, Yichen Sun, B. Teh, Qiang Yu, H. Mai, Jing Tan   +17 more
semanticscholar   +1 more source

Minimally invasive surgery alone compared with intensity-modulated radiotherapy for primary stage I nasopharyngeal carcinoma

Cancer Communications, 2019
Background The National Comprehensive Cancer Network guidelines recommend intensity-modulated radiotherapy (IMRT) as the primary curative treatment for newly diagnosed nasopharyngeal carcinoma (NPC), but the radiation-related complications and relatively
You-Ping Liu, Xing Lv, Xiong Zou, Yi-Jun Hua, Rui You, Qi Yang, Le Xia, Shao-Yan Guo, Wen Hu, Meng-Xia Zhang, Si-Yuan Chen, Mei Lin, Yu-Long Xie, Li-Zhi Liu, Rui Sun, Pei-Yu Huang, Wei Fan, Xiang Guo, Ming-Huang Hong, Ming-Yuan Chen   +19 more
doaj   +1 more source

Incidence, consequences, and predictors of serious chemotherapy‐induced thrombocytopenia in nasopharyngeal carcinoma

Cancer Medicine, 2023
Objectives This study aimed to investigate the incidence, consequences, and predictors of serious chemotherapy‐induced thrombocytopenia (CIT) in nasopharyngeal carcinoma (NPC).
Lu‐Lu Zhang, Xi Chen, Ying‐Ying Huang, Chi‐Xiong Liang, Meng‐Yun Qiang, Zhuo‐Chen Cai, Ze‐Jiang Zhan, Ying Deng, Jia‐Yu Zhou, Hao‐Yang Huang, Xiang Guo, Xing Lv   +11 more
doaj   +1 more source

Single-cell transcriptomics reveals regulators underlying immune cell diversity and immune subtypes associated with prognosis in nasopharyngeal carcinoma

Cell Research, 2020
Nasopharyngeal carcinoma (NPC) is an aggressive malignancy with extremely skewed ethnic and geographic distributions. Increasing evidence indicates that targeting the tumor microenvironment (TME) represents a promising therapeutic approach in NPC ...
Yupei Chen, Jianhua Yin, Wen-Fei Li, Hanjie Li, Dong-Ping Chen, Cuijuan Zhang, J. Lv, Ya-Qin Wang, Xiaomin Li, Junyan Li, Panpan Zhang, Yingqin Li, Qingmei He, Xiao-jing Yang, Yuan Lei, Ling-long Tang, G. Zhou, Y. Mao, Chen Wei, Ke-Xu Xiong, Hong-bo Zhang, Shi-da Zhu, Yong Hou, Ying Sun, M. Dean, I. Amit, Kui Wu, D. Kuang, Guibo Li, Na Liu, Jun Ma   +30 more
semanticscholar   +1 more source

Graphene quantum dots‐based targeted nanoprobes detecting drug delivery, imaging, and enhanced chemotherapy of nasopharyngeal carcinoma

Bioengineering & Translational Medicine, 2021
One of the main clinical treatments for advanced nasopharyngeal carcinoma is chemotherapy, but systemic administration can cause serious adverse reactions.
Chaosheng Yu, Zhen Long, Q. Qiu, Fang Liu, Yiming Xu, Tao Zhang, R. Guo, Wen Zhong, Shuixian Huang, Shuaijun Chen   +9 more
semanticscholar   +1 more source

Nasopharyngeal carcinoma

Current Treatment Options in Oncology, 2002
Nasopharyngeal carcinoma is usually present as locally advanced (stage III or IV) disease. Before 1980, the primary treatment was radiotherapy. The 5-year survival rate of patients with stage IVM0 across the world was less than 30%. Local, regional, and systemic recurrences are high in these patients and contributed to the poor survival.
Muhyi Al Sarraf, Maryada S. Reddy
openaire   +5 more sources

Spatial heterogeneity of immune infiltration predicts the prognosis of nasopharyngeal carcinoma patients

OncoImmunology, 2021
Spatial information on the tumor immune microenvironment is of clinical relevance. Here, we aimed to quantify the spatial heterogeneity of lymphocytes and cancer cells and evaluated its prognostic value in patients with nasopharyngeal carcinoma (NPC ...
Ya-Qin Wang, Xu Liu, Cheng Xu, Wei Jiang, Shuo-Yu Xu, Yu Zhang, Ye Lin Liang, Jun-Yan Li, Qian Li, Yu-Pei Chen, Yin Zhao, Jing-Ping Yun, Na Liu, Ying-Qin Li, Jun Ma   +14 more
doaj   +1 more source